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We have studied the effects of platelet-activating factor (alkyl-acetyl-GPC) on conversion of angiotensin 
I to II. Platelet-activating factor (PAF) had a novel effect on angiotensin I conversion. Pulmonary artery 
endothelial cells converted 30% of rz51]angiotensin I to angiotensin II in the absence of PAF, but their activi- 
ty was greatly stimulated in its presence. When PAF was added to pulmonary artery endothelial cells, the 
conversion of angiotensin I to II was enhanced up to 68%. Maximal stimulation without cellular damage 
was achieved at 10ms M PAF. LysoPAF did not stimulate the conversion of angiotensin I to angiotensin 
II at any concentration used. 
Platelet-activating factor; Angiotensin converting enzyme; (Pulmonary endothelial cell) 
1. INTRODUCTION 
Platelet-activating factor (PAF) is released from 
a number of mammalian cells upon stimulation 
[ 1,2], and appears to be involved in several impor- 
tant cellular events. For example, it causes the ag- 
gregation and degranulation of platelets [3] and 
stimulates arachidonic acid release and subsequent 
thromboxane synthesis [4]. 
Our series of experiments revealed that PAF 
directly acted on Swiss mouse 3T3 fibroblasts, 
releasing arachidonic acid from the cell membrane 
[5], and stimulated the release of prostacyclin from 
aortic smooth muscle cells [6]. In renal epithelial 
cells PAF stimulated PGEz release and calcium 
membrane permeability [7]. These results showed 
that there was a possibility that PAF directly acted 
on renal and vascular cells, and regulated vascular 
tone. In this study experiments have been done to 
elucidate the mechanisms of PAF’s vasoactive ef- 
fects, and to determine the effect of PAF on con- 
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version of angiotensin I to 11 in pulmonary artery 
endothelial cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
3-[1251]Angiotensin 1 (2000 Ci/mmol) and [‘251]- 
angiotensin ll(2OOO Ci/mmol) were obtained from 
Radiochemical Centre, Amersham (England). An- 
giotensin I, 1-0-hexadecyl-2-acetyl-phosphoryl- 
choline (Cl 6-PAF) and lysophosphorylcholine- l  
0-hexadecyl (C164ysoPAF) were obtained from 
Sigma (St. Louis, MO). 1-0-Octadecyl-2-acetyl- 
phosphorylcholine (Cl%PAF) and lysophos- 
phoryldholine-1-0-octadecyl (Cl%lysoPAF) were 
purchased from Bachen Feinchemikalien AG 
(Bubendorf, Switzerland). All other materials were 
of reagent purity. 
2.2. Cell culture 
Bovine pulmonary artery endothelial cells 
(PAEC) were obtained from Flow Laboratory 
(England), and maintained in Eagle’s Minimum 
essential medium (MEM) supplemented with 10% 
fetal bovine serum (FBS). The dishes were in- 
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cubated at 37°C in 5% CO2/95% air atmosphere 
[8]. Cells grown to confluence were subcultured at 
2 x lo5 cells/dish in 3 ml of MEM containing 10% 
FBS in 60-mm dishes [9]. Cultures established in 
this manner with cells between passages 20 and 50 
were used throughout the study. 
2.3. Angio tensin I con version 
Studies into the conversion of angiotensin I (AI) 
to angiotensin II (AII) were done using PAEC. 
Triplicate cultures of 2 x 10’ cells were plated in 
60-mm dishes with 10% FBS supplemented 
medium, and incubated for 1 week to reach con- 
fluence. Confluent cultures were used for all 
assays. Cells were washed with fresh MEM and 
then incubated with 0.3% FBS supplemented 
MEM for 24 h at 37°C. After washing the cells 
again, [1251]AI (0.1 pCi/50 nmol) was added to the 
dishes and incubated for up to 60 min at 37°C with 
or without PAF. [1251]AI was separated from 
[iz51]AII on ODS columns (Sep Pak, Waters 
Associates, Milford, MA) [9], which had been 
previously equilibrated with 10 ml of Krebs- 
Henselites buffer, followed by 20 ml of 0.i M 
sodium phosphate buffer, pH 5.7. The sample was 
loaded on to the column and washed with 2 ml of 
0.1 M sodium phosphate buffer. A solution 
(8.0 ml) of 80% phosphate buffer, 20% ACN (pH 
5.7), was then passed through the column, and the 
fractions collected in tubes for measurement of 
radioactivity. This was followed by 5 ml of 0.1 M 
phosphate buffer (25%), 75% ACN (pH 5.7), 
which was also collected in fractions and counted. 
The columns were regenerated by washing with 
5 ml of 100% ACN. 
2.4. Cytotoxicity assay 
Cells were cultured in the same manner as 
described for the assay of AI converting study ex- 
cept that no [1251]AI was used. Cell viability was 
assessed by the ability to exclude 0.2% nigrosin 
dye for 20 min at room temperature using an in- 
verted microscope with phase optics [lo]. 
3. RESULTS 
3.1. Stimulation of AI conversion to AZZ 
Fig. 1. shows the elution pattern of AI and AII. 
They were separated by the stepwise ACN gradient 
system. 
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Fig.1. Elution profiles for AI (0) (0.1 &i) and AI1 (a) 
(0.1 &i). AI and AI1 were eluted by a stepwise solvent 
system of acetonitril described in section 2. 
The effect of PAF on conversion of AI to AI1 
was determined by the addition of [12’I]AI to en- 
dothelial cells, and incubating with the indicated 
concentration of PAF for 20 min. About 30% of 
AI was converted to AI1 in PAF’s absence. Addi- 
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Fig.2. Effect of PAF on angiotensin conversion. Endo- 
thelial cells were plated and assayed as described in sec- 
tion 2. Points represent means f SE. C16-PAF (o), 
C18-PAF (o), C16-1ysoPAF (A), C18-1ysoPAF (A). 
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tion of either C16-PAF or C18-PAF markedly 
enhanced the conversion dose-dependently (fig.2), 
with the two forms of PAF showing no difference 
in their enhancing ability. The maximum conver- 
sion of AI to AI1 by PAF was 68% at lo-’ M. 
Neither Cl6-1ysoPAF nor C18-1ysoPAF had any 
effect on AI conversion to AII. As shown in fig.3, 
the angiotensin conversion reaction was linear for 
20 min both with and without PAF. Thus, both 
C16- and C18-PAF (1 PM) stimulated the conver- 
sion of AI to AI1 from the beginning of the reac- 
tion (fig.3). 
3.2. Cytotoxicity 
At higher concentrations of PAF cells were kill- 
ed. The addition of PAF (10-3-10-2 M) to a cell 
population caused profound changes in cellular 
morphology to occur. At this time, the cells were 
found to stain strongly with 0.2% nigrosin (fig.4). 
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Fig.3. Time course of angiotensin conversion. Cells were 
cultured as described in section 2. Then AI was added 
and incubated for the indicated period (0) with or 
without 1 pCi PAF (0). Points represent means f SE. 
(m) Cell-free dishes with PAF. 
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Fig.4. Cytotoxicity. Parallel cultures were established as 
in fig.2. Cells were killed at 20 min after treatment by 
failure to exclude 0.2% nigrosin dye for 20 min at room 
temperature. A total of 250 cells on each dish were 
counted and averages (mean + SE) plotted. C16-PAF 
(0). ClI-PAF (0). 
4. DISCUSSION 
PAF is a potent lipid mediator that is strongly 
implicated in the pathogenesis of acute allergic and 
inflammation reaction [2,3], and in vasodilation 
[11,12]. 
In the present study, we found a novel PAF ef- 
fect on AI conversion to AII. It is well-known that 
bradykinin, a potent blood pressure-lowering sub- 
stance, and angiotensin are hydrolyzed by the same 
enzyme [13]. Hydrolysis of AI yields AII, the most 
potent of known mammalian vasopressor hor- 
mones, which is released into the systemic arterial 
circulation. The net result is that a blood pressure- 
raising substance is formed and a blood pressure- 
lowering substance is inactivated [ 131. From this 
point of view, stimulation of angiotensin conver- 
sion by PAF may play an important role for blood 
pressure regulation. Further investigations on the 
mechanism of the effects of PAF on angiotensin 
converting enzyme are under way. 
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